MOUNTAIN VY MD INC - MVMDF STOCK NEWS

Welcome to our dedicated page for MOUNTAIN VY MD news (Ticker: MVMDF), a resource for investors and traders seeking the latest updates and insights on MOUNTAIN VY MD stock.

Mountain Valley MD Inc (MVMDF) is a biotech company focused on utilizing its patented Quicksome™ technology to improve drug delivery and bioavailability. The company's core business involves developing innovative solutions for improving the effectiveness of pharmaceuticals, vaccines, and nutraceuticals. With a strong emphasis on research and development, Mountain Valley MD Inc has been making strides in the medical field by enhancing the absorption rates of various compounds. Their partnerships with leading healthcare organizations have enabled them to expand their reach and enhance their product portfolio. The company's commitment to innovation and scientific excellence has positioned them as a key player in the biotech industry.

08/02/2024 09:00 AM

News

Mountain Valley MD Provides Business Update, Advances Commercialization

Rhea-AI Summary

Mountain Valley MD Holdings Inc. (MVMD) provided a business update on its three core lines: Nutraceuticals, Agriculture, and Husbandry Animals/Aquatic Species. Key developments include:

1. Nutraceuticals: Completed setup for Quicksome™ technology production. Launched Eons Deeper Sleep product with Circadian Wellness. Internal testing showed improved sleep metrics.

2. Agriculture: Acquired exclusive license for Agrarius agricultural technology in the Americas and Caribbean. Obtained product registration in EU, 44 US states, Canada, and Brazil. Launched Performance Guarantee Program for North American farmers.

3. Husbandry/Aquatic: Developed Soluvec™ 1% (solubilized Ivermectin) for animal applications. Licensed to a partner in Bangladesh for fish feed coating, with shipments planned for Q3 2024.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

0.78%

Tags

04/24/2024 08:30 AM

News

Mountain Valley MD Announces Acquisition of Exclusive License for Agrarius, Launch of Performance Guarantee Program

Rhea-AI Summary

Mountain Valley MD Holdings Inc. announces the acquisition of an exclusive license for Agrarius from Agrarius Corp., along with the launch of a Performance Guarantee Program. The Technology is aimed at increasing crop yields, reducing fertilizer usage, and enhancing plant resilience. The Performance Guarantee Program ensures clients pay for the product only after achieving performance enhancements, demonstrating the product's disruptive nature while reducing financial risk for clients. Terms of the agreement include a one-time license fee of USD $1,325,000 paid in common shares and cash.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

18.46%

Tags

04/08/2024 08:30 AM

News

Mountain Valley MD Announces Stock Option Grant

Rhea-AI Summary

Mountain Valley MD Holdings Inc. (MVMDF) granted 3,000,000 stock options under its Stock Option Plan. The Options vest over time and are exercisable at $0.06 per share, aiming to align team focus on long-term shareholder value.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

3.46%

Tags

03/01/2024 09:15 AM

News

Mountain Valley MD Provides Business Update, Appoints New CFO

Rhea-AI Summary

Mountain Valley MD Holdings Inc. provides a comprehensive business update, highlighting progress in nutraceuticals, agriculture, and husbandry animals/aquatic species. The company launched the Eons Deeper Sleep product using its Quicksome™ technology, achieved positive results in Agrarius trials exceeding expectations, and plans to introduce Soluvec™ 1% Coated Fish Feed in Bangladesh. Additionally, the appointment of a new CFO, Matt Anderson, brings extensive financial expertise to support the company's growth phase.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-0.34%

Tags

12/15/2023 04:30 PM

News

Mountain Valley MD Announces Planned Appointment of New CFO Effective January 15, 2024

Rhea-AI Summary

Mountain Valley MD Holdings Inc. (MVMD) appoints Yong Yao as Chief Financial Officer, accepting the resignation of Lucie Letellier due to health issues. Mr. Yao brings extensive financial expertise, having secured significant financing and led successful growth in previous roles. The company grants Mr. Yao stock options to purchase 500,000 common shares.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

6.58%

Tags

09/07/2023 06:01 PM

News

Mountain Valley MD Announces Appointment of New CFO

Rhea-AI Summary

Mountain Valley MD Holdings Inc. appoints Lucie Letellier as CFO, bringing her extensive financial expertise to support the company's commercialization growth phase and international operations. Letellier's proven track record and leadership skills will be invaluable. The company has granted Letellier stock options to purchase 500,000 common shares.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

3.18%

Tags

08/10/2023 04:35 PM

News

Mountain Valley MD Provides Business Update

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

25.96%

Tags

08/09/2023 08:58 PM

News

Mountain Valley MD Announces Publication of Soluvec™ Trial Data in Therapeutic Delivery

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

3.04%

Tags

05/08/2023 09:15 AM

News

Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

13.21%

Tags

03/06/2023 08:10 PM

News

Mountain Valley MD Announces Stock Option Grant

Rhea-AI Summary

Mountain Valley MD Holdings Inc. (CSE: MVMD) (OTCQB: MVMDF) has granted 3,220,000 stock options to its directors, officers, and consultants as part of its Stock Option Plan. The options will vest over a period of time, with 20% available immediately, 30% after six months, and 50% after one year. These options are part of MVMD’s strategy to align team efforts with business goals and enhance shareholder value. The company focuses on commercializing key technologies, including Quicksome™ and Quicksol™ formulations, aimed at improving health and agricultural yields.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-1.3%

Tags

FAQ

What is the current stock price of MOUNTAIN VY MD (MVMDF)?

The current stock price of MOUNTAIN VY MD (MVMDF) is $0.017878 as of December 23, 2024.

What is the market cap of MOUNTAIN VY MD (MVMDF)?

The market cap of MOUNTAIN VY MD (MVMDF) is approximately 6.3M.

What is Mountain Valley MD Inc known for?

Mountain Valley MD Inc is known for its patented Quicksome™ technology, which improves drug delivery and bioavailability.

What is the core business of Mountain Valley MD Inc?

The core business of Mountain Valley MD Inc involves developing innovative solutions to enhance the effectiveness of pharmaceuticals, vaccines, and nutraceuticals.

How does Mountain Valley MD Inc contribute to the medical field?

Mountain Valley MD Inc contributes to the medical field by improving absorption rates of various compounds, leading to more effective treatments.

What partnerships does Mountain Valley MD Inc have?

Mountain Valley MD Inc has partnerships with leading healthcare organizations that help them expand their reach and enhance their product portfolio.

What sets Mountain Valley MD Inc apart in the biotech industry?

Mountain Valley MD Inc's commitment to innovation and scientific excellence has positioned them as a key player in the biotech industry.

How does Mountain Valley MD Inc focus on research and development?

Mountain Valley MD Inc places a strong emphasis on research and development to continue making strides in the medical field.

What is the goal of Mountain Valley MD Inc's technology?

The goal of Mountain Valley MD Inc's technology is to improve drug delivery and absorption rates for better treatment outcomes.

What is the significance of Mountain Valley MD Inc's Quicksome™ technology?

The significance of Mountain Valley MD Inc's Quicksome™ technology lies in its ability to enhance the bioavailability of pharmaceuticals, vaccines, and nutraceuticals.

How does Mountain Valley MD Inc contribute to healthcare advancements?

Mountain Valley MD Inc contributes to healthcare advancements by improving the effectiveness of medications through their innovative technology.

What is the vision of Mountain Valley MD Inc for the future?

Mountain Valley MD Inc aims to continue pioneering advancements in drug delivery technology to revolutionize healthcare treatments.

What can investors expect from Mountain Valley MD Inc?

Investors can expect continued growth and innovation from Mountain Valley MD Inc as they expand their product offerings and solidify their position in the biotech industry.